BMO Kicks Off Coverage of 4 Biotech Players

Four firms in the biotech space will now receive coverage from the investor research arm of...

January 28th, 2020

23andMe Working on New Drug Based on Users’ Genetics

23andMe is teaming up with Spanish drugmaker Almirall to develop an antibody that treats certain inflammatory...

January 13th, 2020

5 Top Genetics News Stories of 2019

What caught the attention of readers in the genetics market this year? We've compiled a list...

December 10th, 2019

5 Top NASDAQ Genetics Stocks of 2019

As 2019 comes to a close, the Investing News Network is profiling the five top genetics...

December 9th, 2019

Top 10 Stem Cell Companies On The NASDAQ

The global stem cell therapy market is expected to grow at a CAGR of 36 percent...

December 2nd, 2019

Alnylam Gets FDA Nod for Rare Disease Drug

The FDA's approval of Alnylam's Gilvaari treatment is the first approval of its kind for acute...

November 20th, 2019

CRISPR and Vertex Release Positive Gene-editing Results

This is the first time CRISPR/Cas9 gene-editing technology has been used in human trials to treat...

November 19th, 2019

Get the latest Genetics Investing stock information

Get the latest information about companies associated with Genetics Investing Delivered directly to your inbox.

Genetics Investing